Patent No. EP2621496 (titled "Crystalline Naloxol-Peg Conjugate") was filed by Astrazeneca on Sep 29, 2011. The application was issued on Dec 12, 2018.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
| Company | Opposition Date | Representative |
|---|---|---|
| STADA ARZNEIMITTEL | Sep 16, 2016 | KERNEBECK |
| ABG PATENTES | Sep 16, 2016 | ABG PATENTES |
| GENERICS UK | Sep 16, 2016 | COOKE |
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Apr 25, 2022
Apr 25, 2022
Apr 25, 2022
Nov 15, 2018
Nov 15, 2018
Nov 15, 2018
Nov 15, 2018
Nov 9, 2018
Oct 30, 2018
Oct 30, 2018
Oct 30, 2018
Oct 30, 2018
Oct 30, 2018
Oct 15, 2018
Jul 23, 2018
Jul 23, 2018
Jul 23, 2018
Jul 23, 2018
Jul 23, 2018
Jul 3, 2018
Jul 2, 2018
Apr 19, 2018
Apr 11, 2018
Mar 28, 2018
Mar 26, 2018
Mar 26, 2018
Mar 22, 2018
Mar 21, 2018
Mar 19, 2018
Mar 19, 2018
Mar 19, 2018
Mar 19, 2018
Mar 19, 2018
Mar 19, 2018
Mar 19, 2018
Mar 19, 2018
Mar 19, 2018
Mar 19, 2018
Mar 19, 2018
Mar 19, 2018
Mar 19, 2018
Mar 19, 2018
Mar 19, 2018
Mar 19, 2018
Jan 24, 2018
Jan 23, 2018
Jan 23, 2018
Jan 23, 2018
Jan 18, 2018
Jan 18, 2018
Jan 18, 2018
Jan 18, 2018
Dec 20, 2017
Dec 20, 2017
Dec 20, 2017
Dec 14, 2017
Dec 14, 2017
Dec 14, 2017
Dec 14, 2017
Dec 4, 2017
Dec 4, 2017
Dec 4, 2017
Nov 30, 2017
Nov 30, 2017
Nov 30, 2017
Nov 27, 2017
Nov 27, 2017
Nov 27, 2017
Nov 24, 2017
Nov 24, 2017
Nov 24, 2017
Nov 24, 2017
Nov 24, 2017
Nov 24, 2017
Nov 24, 2017
Nov 24, 2017
Nov 21, 2017
Nov 21, 2017
Nov 21, 2017
Nov 17, 2017
Nov 17, 2017
Nov 17, 2017
Nov 14, 2017
Nov 14, 2017
Nov 14, 2017
Oct 23, 2017
Oct 20, 2017
Oct 20, 2017
Oct 16, 2017
Oct 16, 2017
Oct 16, 2017
Jun 29, 2017
May 24, 2017
May 4, 2017
Apr 24, 2017
Apr 20, 2017
Apr 20, 2017
Apr 18, 2017
Apr 13, 2017
Apr 13, 2017
Apr 13, 2017
Apr 13, 2017
Apr 13, 2017
Apr 13, 2017
Apr 13, 2017
Apr 13, 2017
Apr 13, 2017
Apr 13, 2017
Apr 13, 2017
Feb 28, 2017
Feb 28, 2017
Feb 28, 2017
Feb 23, 2017
Feb 23, 2017
Feb 23, 2017
Feb 23, 2017
Feb 23, 2017
Feb 23, 2017
Feb 23, 2017
Feb 23, 2017
Feb 23, 2017
Feb 23, 2017
Feb 15, 2017
Feb 15, 2017
Feb 8, 2017
Feb 8, 2017
Feb 8, 2017
Oct 25, 2016
Oct 25, 2016
Oct 25, 2016
Oct 25, 2016
Sep 28, 2016
Sep 19, 2016
Sep 19, 2016
Sep 19, 2016
Sep 19, 2016
Sep 19, 2016
Sep 19, 2016
Sep 19, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Sep 16, 2016
Aug 16, 2016
Dec 17, 2015
Dec 2, 2015
Nov 19, 2015
Nov 5, 2015
Oct 30, 2015
Oct 30, 2015
Oct 30, 2015
Oct 30, 2015
Oct 27, 2015
Oct 27, 2015
Oct 21, 2015
Oct 21, 2015
Oct 21, 2015
Oct 9, 2015
Sep 28, 2015
Sep 28, 2015
Sep 28, 2015
Sep 28, 2015
Sep 28, 2015
Sep 28, 2015
Sep 28, 2015
Jul 16, 2015
Jul 16, 2015
Jul 16, 2015
Jul 16, 2015
Jun 19, 2015
Mar 31, 2015
Mar 31, 2015
Mar 19, 2015
Mar 19, 2015
Mar 19, 2015
Mar 10, 2015
Mar 10, 2015
Mar 10, 2015
Mar 10, 2015
Mar 10, 2015
Mar 10, 2015
Sep 12, 2014
Aug 26, 2014
Aug 26, 2014
Aug 26, 2014
Aug 14, 2014
Apr 24, 2014
Apr 24, 2014
Feb 18, 2014
Feb 18, 2014
Jan 9, 2014
Jan 9, 2014
Jan 9, 2014
Jul 10, 2013
Jul 2, 2013
May 15, 2013
May 15, 2013
May 15, 2013
May 15, 2013
May 15, 2013
May 15, 2013
May 15, 2013
May 15, 2013
May 15, 2013
Apr 17, 2013
Apr 17, 2013
Apr 17, 2013
Apr 17, 2013
Apr 15, 2013
Feb 8, 2013
Apr 25, 2012
Apr 5, 2012
Apr 5, 2012